Metraipolis › archive › dc_cdc1b2becdac

Potential utility of PPARγ agonists in targeting chronic myeloid leukemia stem cells — Europe PMC PMID:41735647

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41735647
DOI
10.1007/s00277-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-05T12:38:37.310Z
SHA-256 of the archived text
8157806011d5bf4868ce7334638f97e88d074f88ea8ca394f2597502a0db81dd
Stable URL of this page
https://metraipolis.com/documento/dc_cdc1b2becdac

How to cite

Potential utility of PPARγ agonists in targeting chronic myeloid leukemia stem cells — Europe PMC PMID:41735647 — Europe PMC (en), https://europepmc.org/article/MED/41735647 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cdc1b2becdac (Metraipolis archive dc_cdc1b2becdac, sha256 8157806011d5bf4868ce7334638f97e88d074f88ea8ca394f2597502a0db81dd)
BibTeX
@misc{dccdc1b2becdac,
  title = {Potential utility of PPARγ agonists in targeting chronic myeloid leukemia stem cells — Europe PMC PMID:41735647},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41735647},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cdc1b2becdac; sha256 8157806011d5bf4868ce7334638f97e88d074f88ea8ca394f2597502a0db81dd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41735647. Agents can read the archived copy with the MCP tool read_document.